Xunming Cui is a China Associate in the Corporate practice of Paul Hastings. His practice focuses on mergers and acquisitions and securities transactions, including initial public offerings, private investment in public equity, and follow-on offerings.
Mr. Cui is fluent in English and Mandarin.
Cornell Law School, J.D., 2017
Peking University, B.A., 2012
Advised Fosun Pharmaceutical, a leading Chinese healthcare group, in the US$1.44 billion sale of stakes in United Family Healthcare along with TPG to New Frontier Corporation.